Bio-Tech Bonanza: XBI Leading the Pack
As the trading bell rings, the SPDR S&P Biotech ETF is stealing the spotlight, surging ahead by a remarkable 4% today. Noteworthy components of this ETF are shining brightly, with Viking Therapeutics witnessing a staggering 99.7% surge, and Beam Therapeutics following closely with a 32.6% uptick in share value.
Gold Miners Feeling the Weight: GDXJ Declines
Conversely, the Junior Gold Miners ETF is facing a bit of a slump, down approximately 0.6% in today’s tumultuous afternoon trading session. Among the constituents of this ETF struggling to stay afloat are Oceanagold, witnessing a 5.6% dip, and Gold Royalty, not far behind with a 5.1% decline on the day.
VIDEO: Tuesday’s ETF Movers: XBI, GDXJ
The author’s musings and insights are solely his own and not necessarily a reflection of the views held by Nasdaq, Inc.
